China Universal Asset Management Company’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-282
Closed -$10K 451
2022
Q3
$10K Buy
+282
New +$10K ﹤0.01% 209